Application Nr Approved Date Route Status External Links
ANDA207264 None Intramuscular None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Dihydroergotamine Mesylate Injection Is Indicated For The Acute Treatment Of Migraine Headaches With Or Without Aura And The Acute Treatment Of Cluster Headache Episodes.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Dihydroergotamine Mesylate DIHYDROERGOTAMINE MESYLATE ZINC3978005

Comments